CARLIE DANIEL: Open Payments
NPI 1265276737 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 77 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $398 · 2025 $1,617
Food & beverage: $1,340Education: $277
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $284 |
| UCB, Inc. | 16 | $240 |
| Janssen Biotech, Inc. | 6 | $187 |
| ABBVIE INC. | 9 | $176 |
| PFIZER INC. | 11 | $139 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Organogenesis Inc. | 5 | $90 |
| Galderma Laboratories, L.P. | 2 | $77 |
| GENZYME CORPORATION | 2 | $62 |
| Incyte Corporation | 2 | $53 |
Products named: DUPIXENT, Bimzelx, TREMFYA, RINVOQ, CIBINQO, LITFULO, SKYRIZI, OPZELURA.
Industry payments across GA — which companies pay providers there.
